Centiva Capital’s Otonomy, Inc. OTIC Stock Holding History

Centiva Capital’s Portfolio OTIC Stock Details OTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-11,904	Closed	-$46K	–	209
2018 Q2	$46K	Buy	+11,904	New	+$49.5K	0.01%	96

Other funds holding OTIC

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Centiva Capital's OTIC Position: Q3 2018 in Review

Centiva Capital sold out of Otonomy, Inc. (OTIC) in Q3 2018, closing a stake of 11,904 shares — an estimated $46K sold.

Centiva Capital first reported a position in OTIC in Q2 2018 and held it in 1 quarter. The position peaked at $46K in Q2 2018. 58 funds tracked by Wall St. Rank hold OTIC as of Q3 2018.

Centiva Capital reported no remaining Otonomy, Inc. position as of Q3 2018 after selling out during the quarter.
Centiva Capital sold 11,904 Otonomy, Inc. shares in Q3 2018, an estimated $46K.
Centiva Capital first reported a position in Otonomy, Inc. in Q2 2018 and held it in 1 quarter.
Centiva Capital's Otonomy, Inc. position peaked at $46K in Q2 2018.
58 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2018.

Based on Centiva Capital's 13F filing for Q3 2018, filed 14 Nov 2018.